tiprankstipranks
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
US Market

Adaptimmune Therapeutics (ADAPY) Technical Analysis

1,254 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
4Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.

Adaptimmune Therapeutics (ADAPY) Pivot Points

Mar 30, 2026, 07:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.01
0.01
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.01
0.01
0.01
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAPY) Moving Averages

Mar 30, 2026, 07:04 AM
Period
Simple
Exponential
MA5
0.02Sell
0.02Buy
MA10
0.02Buy
0.02Buy
MA20
0.02Buy
0.02Buy
MA50
0.02Sell
0.03Sell
MA100
0.03Sell
0.05Sell
MA200
0.10Sell
0.11Sell
Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.05, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.02, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.03, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.10, creating a Sell signal.

Adaptimmune Therapeutics (ADAPY) Technical Indicators

Mar 30, 2026, 07:04 AM
Name
Value
Implied Action
RSI (14)
49.33
Neutral
STOCH (9,6)
80.00
Sell
STOCHRSI (14)
75.56
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
68.21
Sell
Williams %R
-20.00
Buy
CCI (14)
30.53
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
93.07
Buy
ROC
0.00
Buy
Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 49.33, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 68.21, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is 30.53, creating a Neutral signal.

FAQ

Is ADAPY a Buy, Hold, or Sell?
Based on ADAPY’s technical indicators, ADAPY is a Sell.
    What is ADAPY’s RSI (14)?
    ADAPY’s RSI (14) is 49.33, which suggests ADAPY is a Neutral.
      What is ADAPY’s MACD?
      ADAPY’s MACD is >-0.01, which suggests ADAPY is a Sell.
        What is ADAPY’s 5-day moving average?
        ADAPY’s 5-day moving average is 0.02, which suggests ADAPY is a Sell.
          What is ADAPY’s 20-day moving average?
          ADAPY 20-day moving average is 0.02, which suggests ADAPY is a Buy.
            What is ADAPY’s 50-day moving average?
            ADAPY’s 50-day moving average is 0.02, which suggests ADAPY is a Sell.
              What is ADAPY’s 200-day moving average?
              ADAPY’s 200-day moving average is 0.10, which suggests ADAPY is a Sell.
                What is ADAPY’s Williams % R (14)?
                ADAPY’s Williams % R (14) is -20.00, which suggests ADAPY is a Buy.
                  What is ADAPY’s CCI (14)?
                  ADAPY’s CCI (14) is 30.53, which suggests ADAPY is a Neutral.